| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief of Research | Chief of Research | Chief Scientific &Manufact.
1 company
Cox Bryan F. serves as a Chief of Research at TLSI. Across recent SEC filings that breaks down to 0 buys and 6 sells. Those positions are worth an estimated $715K at current prices.
Historically, Cox Bryan F.'s trades have earned a middling insider score of 57/100 across 5 rated trades. Over a 12-month horizon, 50.0% of those trades were profitable, with an average 12-month return of +18.7%.
The biggest single holding is TLSI (~$715K) as Chief of Research. The recent filings there lean toward selling, a net 8,558 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 5, 2026 | TLSI Trisalus Life Sciences, Inc. | Chief of Research | Sell | 296 | $4.39 | $1,299.44 | -0.2% | - | - | |
| Mar 16, 2026 | TLSI Trisalus Life Sciences, Inc. | Chief of Research | Sell | 3,184 | $4.11 | $13,085.45 | -1.9% | +1.9% | - | |
| May 19, 2025 | TLSI Trisalus Life Sciences, Inc. | Chief of Research | Sell | 4,764 | $5.18 | $24,677.52 | -3.8% | -6.2% | -39.2% | |
| Oct 5, 2024 | TLSI Trisalus Life Sciences, Inc. | Chief Scientific &Manufact. | Sell | 314 | $4.44 | $1,394.16 | -0.4% | +10.3% | +1.8% |